跳至主要内容
临床试验/NCT04548609
NCT04548609
终止
不适用

Transcranial Direct Current Stimulation (tDCS) Modulation of Neurocognitive Processes Underlying Pediatric Obsessive Compulsive Disorder (OCD)

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 6 人2021年1月25日

概览

阶段
不适用
干预措施
Transcranial Direct Current Stimulation
疾病 / 适应症
Obsessive-Compulsive Disorder
发起方
Massachusetts General Hospital
入组人数
6
试验地点
1
主要终点
Change in Stop Signal Task
状态
终止
最后更新
上个月

概览

简要总结

In this study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in modulating aberrant neurocognitive processes implicated in pediatric patients with obsessive compulsive disorder (OCD).

详细描述

In this study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in modulating aberrant neurocognitive processes implicated in pediatric patients with obsessive compulsive disorder (OCD). The investigators propose two arms of the study that will investigate fear extinction learning and inhibitory control in one arm (A), and goal orientated versus habit-based behavior and inhibitory control in the other (B). All subjects will undergo three study conditions: two with active tDCS to each of two different brain targets and one under sham tDCS. The order of stimulation (sham or active tDCS) will be randomized.

注册库
clinicaltrials.gov
开始日期
2021年1月25日
结束日期
2025年3月5日
最后更新
上个月
研究类型
Interventional
研究设计
Crossover
性别
All

研究者

责任方
Principal Investigator
主要研究者

Joan A Camprodon, MD MPH PhD

Chief of Division of Neuropsychiatry, Director of TMS Clinic, Director of Lab for Neuropsychiatry and Neuromodulation

Massachusetts General Hospital

入排标准

入选标准

  • Outpatient youth between the ages 10-17 years
  • Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS) ≥16 (moderately severe). OCD must be determined to be the primary or co-primary diagnosis using the The Schedule for Affective Disorders and Schizophrenia for School-Age Children- Computer administered version (KSADS-COMP) based on all available information.
  • Child has a full-scale IQ≥85 as assessed on the Wechsler Abbreviated Scale of Intelligence® Second Edition (WASI®-II) (within 90% CI). To decrease participant burden, the WASI®-II will only be conducted in cases of suspected intellectual disability after meeting with the PI.
  • English speaking.

排除标准

  • Receiving concurrent psychotherapy for subject's OCD (except maintenance).Subjects receiving pre- established concurrent psychotherapy for at least 8 weeks regarding other psychological issues are eligible for enrollment.
  • New Treatments: Initiation of an antidepressant within 12 weeks before study enrollment or an antipsychotic 6 weeks before study enrollment. No new alternative medications, nutritional or therapeutic diets within 6 weeks of study enrolment.
  • Established Treatment changes: Any change in established psychotropic medication (e.g., antidepressants, anxiolytics, stimulant, alpha agonist) within 8 weeks before study enrollment (6 weeks for antipsychotic). Alternative medications must be stable for 6 weeks prior to baseline. Any medications must remain stable during treatment; consistent with the National Institute of Health (NIH)-funded Child Anxiety Multimodal Study (CAMS) trial, downward adjustments due to side effects may be acceptable and will be discussed with the study child and adolescent psychiatrist and the community psychiatrist.
  • Current clinically significant suicidality or individuals who have engaged in suicidal behaviors within 6 months will be excluded and referred for appropriate clinical care.
  • Meets Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria for conduct disorder, autism, bipolar, attention deficit hyperactivity disorder (ADHD), Tourette's syndrome, schizophrenia or schizoaffective disorders
  • Youth with hoarding symptoms as they may be conceptually and genetically different from other OCD subtypes.
  • BMI less than 18.
  • Contraindication to tDCS: history or epilepsy, metallic implants in the head and neck, brain stimulators, vagus nerve stimulators, ventriculoperitoneal (VP) shunt, pacemakers.
  • Active substance dependence (except for tobacco).
  • Pregnant or nursing females as the effects of tDCS on pregnancy are unknown.

研究组 & 干预措施

Inhibitory Control/ Fear Extinction

This arm will investigate the effect of tDCS on tasks assessing Inhibitory Control/ Fear Extinction. This group will undergo three sessions of tDCS: two active sessions and one sham session. The order of the sessions is randomized.

干预措施: Transcranial Direct Current Stimulation

Inhibitory Control/ Goal-Orientated vs Habit-Based Behavior

This arm will investigate the effect of tDCS on tasks assessing Inhibitory Control/ Goal-Orientated versus Habit-Based Behavior. This group will undergo three sessions of tDCS: two active sessions and one sham session. The order of the sessions is randomized.

干预措施: Transcranial Direct Current Stimulation

结局指标

主要结局

Change in Stop Signal Task

时间窗: 50 minutes- 20 minutes before and immediately after a single 30 minute tDCS session

Ability to Inhibit a Response Task

Change in Fear Extinction Recall Task

时间窗: Within 12-24 hours after the tDCS session the day before

Degree of recall to a previously extinguished conditioned stimulus

Change in Sequential Spaceship Task

时间窗: 40 minutes- immediately before and 10 minutes after a 30 minute single tDCS session

Ability to increase the proportion of Goal-Orientated versus Habit-Based Behaviour

次要结局

  • Change in EEG readings(90 minutes- 30 minutes before and 30 minutes after a single 30 minute tDCS session)

研究点 (1)

Loading locations...

相似试验